Title: The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.
Journal: Oncotarget 20160510
Title: c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study.
Journal: Fertility and sterility 20160301
Title: Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.
Journal: Reproductive sciences (Thousand Oaks, Calif.) 20160101
Title: Letter: The formation of a semiquinone form of deazaFAD bound to D-amino acid oxidase.
Journal: Journal of the American Chemical Society 19760204
Title: Messoussi A, et al. Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticanceragents. Chem Biol. 2014 Nov 20;21(11):1433-43.
Title: Okada M, et al. The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo. Oncotarget. 2016 May 10;7(19):27021-32.
Title: Palmer SS, et al. Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models. Reprod Sci. 2016 Jan;23(1):11-23.
